Do we consider cardiovascular risk in patients with type 1 diabetes mellitus? a cross-sectional observational study at the canary islands university hospital complex (CHUC)

Diaz Gorrin Kevin David; Rodriguez Oliver Quintero; Fernandez Selena Rodriguez; Fra Javier Panizo; Leon Ocando Ana Paola; Gonzalez Patricia Leon; Oliva Garcia Jose Gregorio; Judith Lopez

doi:10.1530/endoabs.110.EP462

EP462

Prev Next

Section Contents Cite

Endocrine Abstracts (2025) 110 EP462 | DOI: 10.1530/endoabs.110.EP462

ECEESPE2025 ePoster Presentations Diabetes and Insulin (245 abstracts)

Do we consider cardiovascular risk in patients with type 1 diabetes mellitus? a cross-sectional observational study at the canary islands university hospital complex (CHUC)

Kevin David Díaz Gorrín ^1,2 , Óliver Quintero Rodríguez ¹ , Selena Rodriguez Fernandez ¹ , Javier Panizo Fra ¹ , Ana Paola León Ocando ¹ , Patricia León González ¹ , Jose Gregorio Oliva Garcia ^2,3 & Judith Lopez ^1,2

Author affiliations

¹Complejo Hospitalario Universitario de Canarias (CHUC), Servicio de Endocrinología y Nutrición, La Laguna, Spain; ²Universidad de La Laguna (ULL), La Laguna, Spain; ³Complejo Hospitalario Nuestra Señora de Candelaria (CHUNSC), Santa Cruz de Tenerife, Spain

JOINT3499

Introduction: Type 1 diabetes mellitus (T1DM) is a chronic metabolic disease with a high cardiovascular risk (CVR). In addition to maintaining good glycemic control, it is essential to manage other CVR factors to reduce the risk of chronic microvascular and macrovascular complications.

Objectives: • To determine whether patients followed up in Endocrinology consultations at CHUC have LDL levels within the target range according to their CVR group and whether they have been prescribed statins.

• To collect descriptive data on the population (age, sex, and years since T1DM diagnosis).

Materials and Methods: A cross-sectional descriptive study was conducted on 89 patients followed up in outpatient Endocrinology consultations at the Canary Islands University Hospital Complex (CHUC). The latest consultation and laboratory results of a sample of patients who attended consultations between January and May 2024 were analyzed.

Results: • The study population had a mean age of 40.87 years, with 52.8% being women and 47.2% men, and a T1DM duration of 22.4 ± 1.2 years.

• According to European guidelines, CVR stratification was as follows: very high in 61.8%, high in 25.8%, and moderate in 12.4% of patients.

• The LDL levels recorded in the latest laboratory tests were: <55 mg/dL in 4.5%, 55-69 mg/dL in 12.4%, 70-99 mg/dL in 30.3%, 100-115 mg/dL in 19.1%, and >115 mg/dL in 33.7% of patients.

• The percentage of patients within the target LDL range according to their CVR group was: 5.4% in the very high-risk group, 17.39% in the high-risk group, and 36.36% in the moderate-risk group.

• Only 32.6% of the study population had been prescribed a statin.

Conclusions: • In most cases, patients’ LDL levels were not within the target range for their CVR group.

• We propose recording the patient’s CVR group in their medical history and addressing lipid-lowering treatment as part of the comprehensive metabolic management of patients with T1DM.